- Home
- GNLX vs FORR Comparison
GNLX vs FORR Comparison
Compare GNLX & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | FORR |
|---|---|---|
| Founded | 2001 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.8M | 106.6M |
| IPO Year | 2022 | 1996 |
Fundamental Metrics
Financial Performance| Metric | GNLX | FORR |
|---|---|---|
| Price | $2.70 | $6.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | 181.8K | ★ 191.8K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.10 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $4.91 |
| 52 Week High | $8.54 | $11.57 |
Technical Indicators
Market Signals| Indicator | GNLX | FORR |
|---|---|---|
| Relative Strength Index (RSI) | 45.03 | 38.14 |
| Support Level | $2.31 | $5.02 |
| Resistance Level | $2.80 | $6.26 |
| Average True Range (ATR) | 0.16 | 0.46 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 51.13 | 47.39 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.